Healthcare
WellQuest Medical & Wellness Corporation(WEQL)
Live Price
Offline$0.0002
+0.00% today
1Y Change
+100.00%
Window
Jun 23, 2025 → Jun 10, 2026
- Market Cap
- —
- Revenue Growth
- -11.6%
- EPS Growth
- -4.5%
- Dividend Yield
- 0.0%
Coverage: 246 bars · Jun 23, 2025 → Jun 10, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
WellQuest Medical & Wellness Corporation (WEQL) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 23, 2025 → Jun 10, 2026). Baseline metrics include revenue growth of -11.6%, EPS growth of -4.5%, a dividend yield of 0.0%. What stands out right now is revenue -11.6%, EPS -4.5%, free cash flow +83.6% with operating margin -6.3% and ROIC -23.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WEQL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-11.6% vs +7.6% peer median
Operating Margin
Below sector median
-6.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -11.6% and EPS is at -4.5%, with operating margin around -6.3%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WEQL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WEQL Max Drawdown
-93.44%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for WEQL and SPY.
Company Overview
WellQuest Medical & Wellness Corporation
Other OTC
WellQuest Medical & Wellness Corporation provides an integrated medical delivery site with family physician healthcare, preventive/wellness, and medical skin-care services. It operates medical center that provides physician-directed medical service for families and businesses, which offers a range of medical care for adults and children with digital diagnostic tests, including laboratory, X-ray, EKG, and others. The company also offers various immunizations for all ages; and weight loss program, nutritional counseling, allergy testing, fitness consulting, hormone therapy, and therapeutic massage services, as well as designs personalized treatment plans. In addition, it manufactures and sells heart support; bone and joint support; stress, mood, and sleep support; immune support; and vitamins and minerals capsules. Further, the company provides aesthetic services, which include medical spa, laser skin renewal, botox and dermal fillers, skin print technology, facials and derma sweep, Glo minerals, and teeth whitening services. Additionally, it offers corporate wellness, occupational and executive health, genetic testing, and tobacco cessation services. The company was formerly known as HQHealthQuest Medical & Wellness Centers, Ltd. and changed its name to WellQuest Medical & Wellness Corporation in April 2008. WellQuest Medical & Wellness Corporation was incorporated in 2004 and is based in Bentonville, Arkansas.
- Leadership
- Stephen H. Swift
- IPO Date
- Apr 20, 2009
- Employees
- 24
- Street Address
- 3400 Southeast Macy Road
- Mailing
- Bentonville, AR, 72712
- Region
- Bentonville, AR, US
- Reporting Currency
- USD
- Investor Line
- 479-845-0880
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 0.0
- Price/Book
- —
Growth
- Revenue
- -11.6%
- EPS
- -4.5%
- Free Cash Flow
- +83.6%
Profitability
- Gross Margin
- 8.4%
- Operating Margin
- -6.3%
- Net Margin
- -8.1%
- ROE
- 21.0%
- ROIC
- -23.1%
Balance Sheet
- Debt/Equity
- —
- Current Ratio
- 0.12
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.